Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Innate Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Innate Pharma S.A.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

28 Jan 2016 Wright Reports 56 $75.00

Innate Pharma SA: Downgraded to Average

22 Dec 2015 Sadif Analytics Prime 3 $10.00

Innate Pharma SA (IPH) - Financial Analysis Review

Innate Pharma SA (IPH) - Financial Analysis Review Summary Innate Pharma SA (Innate Pharma) is a bio-pharmaceutical company t...

02 Dec 2015 GlobalData 49 $300.00

Company Snapshot - Innate Pharma

A director at Innate Pharma sold 9,960 shares at 14.080EUR and the significance rating of the trade was 53/100. Is that info...

26 Oct 2015 Directors Deals Ltd. 1 $12.00

Is Innate Pharma SA for Long-Term Investors?

16 Oct 2015 Sadif Analytics Prime 12 $25.00

ValuEngine Industry Report for Medical-Drugs(IPHYF)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00

Innate Pharma SA (IPH) - Financial Analysis Review

Innate Pharma SA (IPH) - Financial Analysis Review Summary Innate Pharma SA (Innate Pharma) is a bio-pharmaceutical com...

21 Aug 2015 GlobalData 40 $125.00

Innate Pharma SA: Downgraded to Average

11 Aug 2015 Sadif Analytics Prime 3 $10.00

ValuEngine Industry Report for Medical-drugs(IPHYF)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

22 Jul 2015 ValuEngine, Inc. 10 $49.00